Results 41 to 50 of about 16,213 (201)

Patient‐Reported Outcome Measures and Clinical Performance in Hemophilia: Implications for Person‐Centered Care

Haemophilia, EarlyView.
ABSTRACT Objectives To examine the association between patient‐reported outcome measures (PROMs) and objective measures of clinical performance in children, adolescents, and adults with haemophilia, highlighting their implications for person‐centered care.
Tatyane Oliveira Rebouças Brito, Luiz Ivando Pires Ferreira Filho, Luany Elvira Mesquita Carvalho, Francisco Josimar Girão Júnior, Pedro Everson Alexandre de Aquino, Chiara Bezerra Barreira, Lucilane Maria Sales da Silva   +6 more
wiley   +1 more source

Guía itinerario formativo pregrado y postgrado servicio: Hematología y Hemoterapia

, 2021
Guía do itinerario formativo dos residentes no servizo de Hematoloxía e Hemoterapia do Complexo Hospitalario Universitario de Pontevedra.Guía del itinerario formativo de los residentes en el servicio de Hematología y Hemoterapia del Complejo Hospitalario
Dios Loureiro, Ana María
core   +1 more source

¿Qué debemos conocer los hematólogos sobre la certificación y revalidación periódica del certificado de especialista en hematología?

Revista Hematología
La certificación inicial en Hematología avala que el médico ha adquirido los conocimientos prácticos y teóricos suficientes que le permiten ser reconocido como médico especialista en Hematología.
M. Zerga, N. Tauro, J. Neira
semanticscholar   +1 more source

Challenges of Dengue in Hematological Disease Patients: Descriptive Analysis From the DANGO Registry During the 2023–2024 Outbreak in Argentina

Transplant Infectious Disease, EarlyView.
During the 2023–2024 Argentine dengue outbreak, 33 patients with hematological disease showed high complication rates, frequent hospitalization (64%), severe thrombocytopenia (90%), and 6% dengue‐attributable mortality. Transfusion‐associated cases were documented.
Gustavo Adolfo Méndez, Carla Niveyro, Pedro Andrés Villalba Apestegui, Victoria Isabel Martin, Lucila María Compañy Kec, María Cynthia Tomasino, Mariana del Carmen del Marull, Haydee Ingrid Bernard, Claudia Patricia Lorena Fernández, Flavia Marcela Pelech, Maria Fernanda Tosin, María Fernanda González‐Hobecker, Karen Beatrice Duranona, Angela Daiana Jara, Justus Cornely, Oliver A. Cornely, Jon Salmanton‐García   +16 more
wiley   +1 more source

Mapping syphilis surveillance: Insights into blood donation screening practices worldwide

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Syphilis is caused by the bacterial spirochete Treponema pallidum and can be transmitted through blood transfusion. However, there have been less than 10 documented transfusion‐transmitted cases since World War II.
Michel‐Andrés García‐Otálora, Guillermo Orjuela‐Falla, Carl P. McDonald, Sandra Ramirez‐Arcos, ISBT Transfusion‐Transmitted Infectious Diseases Working Party Subgroup on Bacteria   +4 more
wiley   +1 more source

Eltrombopag Added to Standard Immunosuppressive Treatment as Front‐Line Therapy for Severe Aplastic Anemia: Long‐Term Outcomes of the Phase‐3 Randomized Superiority EBMT‐SAAWP RACE Study

American Journal of Hematology, Volume 101, Issue 10, Page 2520-2532, October 2026.
ABSTRACT The RACE study (NCT02009747) compared horse antithymocyte globulin (hATG) plus cyclosporine A (CsA) ± eltrombopag as initial immunosuppressive treatment (IST) for severe aplastic anemia. Here we report the final 2‐year analysis of this prospective randomized phase III study.
Antonio M. Risitano, Simona Iacobelli, Austin Kulasekararaj, Marleen van Os, Sofie R. Terwel, Joe Tuffnell, Brian Piepenbroek, Morag Griffin, Constantijn J. M. Halkes, Christian Recher, Fiorenza Barraco, Edouard Forcade, Juan Carlos Vallejo, Beatrice Drexler, Jean‐Baptiste Mear, Roochi Trikha, Shreyans Gandhi, Anna Maria Raiola, L. G. M. Daenen, Marco R. de Groot, Etienne Daguindau, Erfan Nur, Wilma Barcellini, Nigel H. Russell, Louis Terriou, Anna Paola Iori, Walter Barberi, Anna Sureda, Isabel Sánchez‐Ortega, Blanca Xicoy, Isidro Jarque, James Cavenagh, Flore Sicre de Fontbrune, Camilla Frieri, Talha Munir, Jennifer M. L. Tjon, Suzanne Tavitian, Aline Praire, Laurence Clement, Florence Rabian, Luana Marano, Anita Hill, Elena Palmisani, Petra Muus, Serena Marotta, Fabiana Cacace, Marica Laurino, Jakob R. Passweg, Gérard Socié, Ghulam J. Mufti, Carlo Dufour, Régis Peffault de Latour, Severe Aplastic Anaemia Working Party of the EBMT   +52 more
wiley   +1 more source

Genomic profiling of Mexican patients with B‐cell precursor acute lymphoblastic leukemia reveals clinically significant somatic and potential germline variants

The Journal of Pathology: Clinical Research, Volume 12, Issue 5, September 2026.
Abstract B‐cell precursor acute lymphoblastic leukemia (preB‐ALL) is characterized by pathogenic variants currently used in precision oncology. However, the mutational landscape of Mexican children with preB‐ALL has not yet been thoroughly explored and defined in terms of the clinical significance.
Daniel Martínez Anaya, María del Rocío Juárez‐Velázquez, Ulises Juárez Figueroa, Michael Dean, Consuelo Salas Labadía, Marian Valladares Coyotecatl, Adriana Reyes León, Norma López Santiago, Luis Juárez Villegas, Marta Zapata Tarrés, Patricia Pérez‐Vera   +10 more
wiley   +1 more source

The Changing Landscape of Maintenance Therapy in Newly Diagnosed Multiple Myeloma: A Systematic Review With Network Meta‐Analysis of the European Myeloma Network (EMN)

American Journal of Hematology, Volume 101, Issue 9, Page 2353-2370, September 2026.
Our meta‐analysis showed significant improvement of PFS with lenalidomide, proteasome inhibitors, and CD38‐based therapies. A significant OS benefit was noted only with lenalidomide in transplant‐eligible (TE) patients, while CD38‐directed therapy showed a trend toward improved OS.
Heinz Ludwig, Evangelos Terpos, Francesca Gay, Niels W. C. J. van de Donk, Sarah Bernhard, Monika Engelhardt, Gordon Cook, Fredrik Schjesvold, Hermann Einsele, Graham Jackson, Charlotte Pawlyn, María‐Victoria Mateos, Sonja Zweegman, Martin Schreder, Meral Beksaç, Christoph Driessen, Enrique M. Ocio, Rakesh Popat, Leo Rasche, Cyrille Touzeau, Pellegrino Musto, Annemiek Broijl, Meletios Dimopoulos, Roman Hajek, Mario Boccadoro, Pieter Sonneveld   +25 more
wiley   +1 more source

Vexas syndrome: a new hematoinflammatory disease

Revista Información Científica, 2023
Reference is made to a new autoinflammatory condition of acquired etiology, named VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic). This syndrome is due to mutations of the ubiquitin enzyme 1 (UBA1) and is most commonly diagnosed in men ...
Roberto Michael Blanco-Alvarez, Sonia Haila Carbonell-Labadie, Margarita Montes de Oca-Carmenaty   +2 more
doaj   +1 more source

Caracterización clínica de pacientes con diagnóstico de eritrocitosis secundaria atendidos en el Servicio de Hematología del Hospital de Especialidades Carlos Andrade Marín, en el periodo de enero a diciembre del 2018 [PDF]

, 2020
La eritrocitosis es una de las patologías más consultadas a nivel mundial, en especial en servicios de Hematología. Dada la variedad de manifestaciones clínicas y características epidemiológicas, su descripción es variable entre cada región, por lo cual,
Céspedes Ribadeneira, Adriana Paulina
core   +1 more source